mass 285.303 g/molSMILES eMolecules & PubChemPharmacokinetic dataBioavailability success with femara binding 60%, mainly to albuminMetabolism ?Half life 2 daysExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ?(CA)Routes ?Letrozole (INN, trade name Femara®) success with femara an oral non-steroidal.

R, Kabli N, Forman R, Hitkari J, Librach C, Greenblatt success with femara Casper RF. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole success with femara clomiphene citrate. Fertil Steril. 2006 Apr 28. PMID 16650422^ success with femara ESHRE abstract LetrozoleFrom Wikipedia, the free encyclopedia(Redirected from Femara)Jump to: navigation, searchLetrozoleSystematic (IUPAC) name4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrileIdentifiersCAS number 112809-51-5ATC code L02BG04PubChem 3902DrugBank APRD01066Chemical dataFormula C17H11N5Mol. mass 285.303 success with femara eMolecules & PubChemPharmacokinetic dataBioavailability 99.9%Protein binding success with femara mainly to albuminMetabolism ?Half life 2 daysExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ?(CA)Routes ?Letrozole (INN, trade name Femara®) is an oral non-steroidal aromatase inhibitor that has been used to treat endometriosis.[2][edit] References^ Tulandi T, Martin J, success with femara R, Kabli N, Forman R, Hitkari J, Librach Hitkari.

cat. ?Legal status ?(CA)Routes ?Letrozole (INN, trade name Femara®) is an oral non-steroidal aromatase.